Category Archives: Uncategorized

Recent publications

Papers Cox AR, Kirkham H. A Case Study of a Graphical Misrepresentation: Drawing the Wrong Conclusions about the Measles, Mumps and Rubella Virus Vaccine. Drug Safety 2007; 30(10): 831-836. Conference presentations Cox AR, Anton C, Marriott JF, Ferner RE. The … Continue reading

Posted in Uncategorized | Comments Off

Prescription charge refund for rofecoxib (Vioxx)

Patients who were taking the now withdrawn drug rofecoxib will be able to claim their last prescription charge back from the company – MSD.

Posted in Uncategorized | Comments Off

International Society of Pharmacovigilance annual meeting 2004

The Centre presented its reseach into encouraging reporters by enhancing feedback at the recent ISOP meeting in Dublin. The PowerPoint presentation may be viewed here. Christopher Anton presents the results of the GP invention study in Dublin.

Posted in Uncategorized | Comments Off

Canadian ADR bulletin published

Health Canada have published their latest Adverse Reaction Newsletter covering fentanyl and respiratory arrest in adolescents, infliximab and etanercept and serious respiratory infections, bitter orange (synephrine) and cardiovascular reactions

Posted in Uncategorized | Comments Off

MHRA advice about Vioxx

MHRA message to healthcare professionals. Press Statement. Questions and Answers.

Posted in Uncategorized | Comments Off

Vioxx (rofecoxib) withdrawn

“The Food and Drug Administration (FDA) today acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. FDA today also issued a Public Health Advisory to inform patients … Continue reading

Posted in Uncategorized | Comments Off

Interaction between lamotrigine and hormonal contraceptives

GlaxoSmithKline and Health Canada have issued a warning about an interaction between lamotrigine (Lamictal) and female hormonal contraceptives. A study has shown significant reductions in the blood concentration of lamotrigine in women taken both. There were also reports of break-through … Continue reading

Posted in Uncategorized | Comments Off

Australian ADR bulletin published

ADRAC have published their latest bulletin featuring: ADRs to pneumococcal vaccine, risk of suicide with high dose tricyclic antidepressants, terbinafine and blood dyscrasias, cholinesterase inhibitors and cardiac arrhythmias, and quinine and thrombocytopenia. http://www.tga.gov.au/adr/aadrb/aadr0410.pdf

Posted in Uncategorized | Comments Off

Our latest bulletin is published

re:Action 30 has just been published with articles on ADRs causing hospital admission, combination antiretrovirals and pancreatitis, photosensitivity reactions and a possible interaction between statins and thiazolidinediones.

Posted in Uncategorized | Comments Off

Anti-depressants in teenagers

“Top officials of the Food and Drug Administration have acknowledged for the first time that antidepressants appeared to lead some children and teenagers to become suicidal. Dr. Robert Temple, director of the food agency’s office of medical policy, said after … Continue reading

Posted in Uncategorized | Comments Off